198 related articles for article (PubMed ID: 28776965)
1. Silicon Phthalocyanines Axially Disubstituted with Erlotinib toward Small-Molecular-Target-Based Photodynamic Therapy.
Chen JJ; Huang YZ; Song MR; Zhang ZH; Xue JP
ChemMedChem; 2017 Sep; 12(18):1504-1511. PubMed ID: 28776965
[TBL] [Abstract][Full Text] [Related]
2. Molecular-target-based anticancer photosensitizer: synthesis and in vitro photodynamic activity of erlotinib-zinc(II) phthalocyanine conjugates.
Zhang FL; Huang Q; Liu JY; Huang MD; Xue JP
ChemMedChem; 2015 Feb; 10(2):312-20. PubMed ID: 25336150
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and in vitro anticancer activity of zinc(II) phthalocyanines conjugated with coumarin derivatives for dual photodynamic and chemotherapy.
Zhou XQ; Meng LB; Huang Q; Li J; Zheng K; Zhang FL; Liu JY; Xue JP
ChemMedChem; 2015 Feb; 10(2):304-11. PubMed ID: 25369981
[TBL] [Abstract][Full Text] [Related]
4. A novel strategy for targeting photodynamic therapy. Molecular combo of photodynamic agent zinc(II) phthalocyanine and small molecule target-based anticancer drug erlotinib.
Zhang FL; Huang Q; Zheng K; Li J; Liu JY; Xue JP
Chem Commun (Camb); 2013 Oct; 49(83):9570-2. PubMed ID: 24018863
[TBL] [Abstract][Full Text] [Related]
5. Axially substituted silicon(IV) phthalocyanine and its quaternized derivative as photosensitizers towards tumor cells and bacterial pathogens.
Ömeroğlu İ; Kaya EN; Göksel M; Kussovski V; Mantareva V; Durmuş M
Bioorg Med Chem; 2017 Oct; 25(20):5415-5422. PubMed ID: 28807573
[TBL] [Abstract][Full Text] [Related]
6. Preparation and in vitro photodynamic activities of novel axially substituted silicon (IV) phthalocyanines and their bovine serum albumin conjugates.
Jiang XJ; Huang JD; Zhu YJ; Tang FX; Ng DK; Sun JC
Bioorg Med Chem Lett; 2006 May; 16(9):2450-3. PubMed ID: 16464589
[TBL] [Abstract][Full Text] [Related]
7. The first silicon(IV) phthalocyanine-nucleoside conjugates with high photodynamic activity.
Shen XM; Zheng BY; Huang XR; Wang L; Huang JD
Dalton Trans; 2013 Aug; 42(29):10398-403. PubMed ID: 23774802
[TBL] [Abstract][Full Text] [Related]
8. Effect of axial ligands on the molecular configurations, stability, reactivity, and photodynamic activities of silicon phthalocyanines.
Luan L; Ding L; Shi J; Fang W; Ni Y; Liu W
Chem Asian J; 2014 Dec; 9(12):3491-7. PubMed ID: 25303635
[TBL] [Abstract][Full Text] [Related]
9. The water soluble axially disubstituted silicon phthalocyanines: photophysicochemical properties and in vitro studies.
Göksel M; Biyiklioglu Z; Durmuş M
J Biol Inorg Chem; 2017 Aug; 22(6):953-967. PubMed ID: 28616663
[TBL] [Abstract][Full Text] [Related]
10. An epidermal growth factor receptor-targeted and endoplasmic reticulum-localized organic photosensitizer toward photodynamic anticancer therapy.
Zhao X; Ma H; Chen J; Zhang F; Jia X; Xue J
Eur J Med Chem; 2019 Nov; 182():111625. PubMed ID: 31442683
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, Photophysical and Photochemical Properties of a Set of Silicon Phthalocyanines Bearing Anti-Inflammatory Groups.
Şahin B; Topal SZ; Atilla D
J Fluoresc; 2017 Jan; 27(1):407-416. PubMed ID: 27858301
[TBL] [Abstract][Full Text] [Related]
12. Preparation and photodynamic activities of silicon(IV) phthalocyanines substituted with permethylated β-cyclodextrins.
Lau JT; Lo PC; Fong WP; Ng DK
Chemistry; 2011 Jun; 17(27):7569-77. PubMed ID: 21598326
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of axially disubstituted quaternized silicon phthalocyanines as a promising photosensitizer for the photodynamic treatment of HCT-116, A549 and SH-SY5Y cancer cell lines.
Özgür Yalçın C; Baş H; Barut B; Özel A; Biyiklioglu Z
Dalton Trans; 2020 Apr; 49(15):4927-4934. PubMed ID: 32232308
[TBL] [Abstract][Full Text] [Related]
14. Phthalocyanine-polyamine conjugates as pH-controlled photosensitizers for photodynamic therapy.
Jiang XJ; Lo PC; Tsang YM; Yeung SL; Fong WP; Ng DK
Chemistry; 2010 Apr; 16(16):4777-83. PubMed ID: 20309976
[TBL] [Abstract][Full Text] [Related]
15. Highly photocytotoxic glucosylated silicon(IV) phthalocyanines. Effects of peripheral chloro substitution on the photophysical and photodynamic properties.
Lo PC; Chan CM; Liu JY; Fong WP; Ng DK
J Med Chem; 2007 May; 50(9):2100-7. PubMed ID: 17394299
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of axially disubstituted silicon phthalocyanines and investigation of photodynamic effects on HCT-116 colorectal cancer cell line.
Sarı C; Eyüpoğlu FC; Değirmencioğlu İ; Bayrak R
Photodiagnosis Photodyn Ther; 2018 Sep; 23():83-88. PubMed ID: 29775760
[TBL] [Abstract][Full Text] [Related]
17. Tumor-selective new piperazine-fragmented silicon phthalocyanines initiate cell death in breast cancer cell lines.
Sarı C; Nalçaoğlu A; Değirmencioğlu İ; Celep Eyüpoğlu F
J Photochem Photobiol B; 2021 Mar; 216():112143. PubMed ID: 33550219
[TBL] [Abstract][Full Text] [Related]
18. Highly photocytotoxic 1,4-dipegylated zinc(II) phthalocyanines. Effects of the chain length on the in vitro photodynamic activities.
Liu JY; Jiang XJ; Fong WP; Ng DK
Org Biomol Chem; 2008 Dec; 6(24):4560-6. PubMed ID: 19039364
[TBL] [Abstract][Full Text] [Related]
19. Light-activatable cannabinoid prodrug for combined and target-specific photodynamic and cannabinoid therapy.
Ling X; Zhang S; Liu Y; Bai M
J Biomed Opt; 2018 Oct; 23(10):1-9. PubMed ID: 30334393
[TBL] [Abstract][Full Text] [Related]
20. A Biotinylated and Endoplasmic Reticulum-Targeted Glutathione-Responsive Zinc(II) Phthalocyanine for Targeted Photodynamic Therapy.
Yu L; Wang Q; Yeung KW; Fong WP; Lo PC
Chem Asian J; 2018 Nov; 13(22):3509-3517. PubMed ID: 29956487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
